| Cefotaxime |
20130419 |
Cefotaxim- MIP, Powder for solution for injection/infusion, 2, g, Pack: 10 |
MIP Pharma GmbH, Германия |
MIP Pharma GmbH, Германия |
31.14 |
6.23 |
37.37 |
4% |
1.25 |
32.39 |
6.48 |
38.87 |
16% |
4.98 |
37.37 |
7.47 |
44.84 |
|
НСР-7006/24.08.2015.; НСР-11082/01.12.2016 г. |
17.12.2016 |
02.01.2017 |
Активен |
2984 |
| Cefotaxime |
20130419 |
Cefotaxim- MIP, Powder for solution for injection/infusion, 2, g, Pack: 10 |
MIP Pharma GmbH, Германия |
MIP Pharma GmbH, Германия |
35.75 |
7.15 |
42.9 |
4% |
1.43 |
37.18 |
7.44 |
44.62 |
16% |
5.72 |
42.9 |
8.58 |
51.48 |
|
НСР-7006/24.08.2015. |
08.09.2015 |
08.09.2015 |
Неактивен |
2984 |
| Cefotaxime |
20130419 |
Cefotaxim- MIP, Powder for solution for injection/infusion, 2, g, Pack: 10 |
MIP Pharma GmbH, Германия |
MIP Pharma GmbH, Германия |
55.68 |
11.14 |
66.82 |
4% |
2.23 |
57.91 |
11.58 |
69.49 |
16% |
8.91 |
66.82 |
13.36 |
80.18 |
|
НСР-4095/10.07.2014 |
25.07.2014 |
25.07.2014 |
Неактивен |
2984 |
| Cefotaxime |
20130418 |
Cefotaxim- MIP, Powder for solution for injection/infusion, 1, g, Pack: 10 |
MIP Pharma GmbH, Германия |
MIP Pharma GmbH, Германия |
30.92 |
6.18 |
37.1 |
4% |
1.24 |
32.16 |
6.43 |
38.59 |
16% |
4.95 |
37.11 |
7.42 |
44.53 |
|
НСР-4095/10.07.2014 |
25.07.2014 |
25.07.2014 |
Неактивен |
2983 |
| Ceftazidime |
20070109 |
Ceftazidime ABR, Powder for solution for injection, 1000, mg, Pack: 5 |
Антибиотик Разград АД, България |
Балканфарма Разград АД, България |
58.54 |
11.71 |
70.25 |
4% |
2.34 |
60.88 |
12.18 |
73.06 |
16% |
9.37 |
70.25 |
14.05 |
84.3 |
промяна на обстоятелства НСР-11443/13.01.2017 г.; НСР-16993/12.10.2018 |
НСР-5968/01.04.2015.; НСР-15721/25.05.2018; НСР-21629/04.06.2020 |
09.06.2018 |
02.07.2020 |
Заличен |
3728 |
| Ceftazidime |
20070109 |
Ceftazidime ABR, Powder for solution for injection, 1000, mg, Pack: 5 |
Антибиотик Разград АД, България |
Балканфарма Разград АД, България |
58.54 |
11.71 |
70.25 |
4% |
2.34 |
60.88 |
12.18 |
73.06 |
16% |
9.37 |
70.25 |
14.05 |
84.3 |
промяна на обстоятелства НСР-11443/13.01.2017 г.; НСР-16993/12.10.2018 |
НСР-5968/01.04.2015.; НСР-15721/25.05.2018 |
09.06.2018 |
02.11.2018 |
Неактивен |
3728 |
| Ceftazidime |
20150170 |
Ceftazidime-MIP, Powder for solution for injection/infusion, 1000, mg, Pack: 10 |
MIP Pharma GmbH, Германия |
MIP Pharma GmbH, Kirkeler Str. 41, 66440 Blieskastel, Германия |
83.89 |
16.78 |
100.67 |
4% |
3.36 |
87.25 |
17.45 |
104.7 |
16% |
13.42 |
100.67 |
20.13 |
120.8 |
|
НСР-7815/28.12.2015; НСР-12505/28.04.2017 г. |
13.05.2017 |
02.06.2017 |
Активен |
4165 |
| Ceftazidime |
20150170 |
Ceftazidime-MIP, Powder for solution for injection/infusion, 1000, mg, Pack: 10 |
MIP Pharma GmbH, Германия |
MIP Pharma GmbH, Kirkeler Str. 41, 66440 Blieskastel, Германия |
97.58 |
19.52 |
117.1 |
4% |
3.9 |
101.48 |
20.3 |
121.78 |
16% |
15.61 |
117.09 |
23.42 |
140.51 |
|
НСР-7815/28.12.2015 |
13.01.2016 |
13.01.2016 |
Неактивен |
4165 |
| Ceftazidime |
20100301 |
CEFTAZIDIME PANPHARMA, Powder for solution for injection, 1000, mg, Pack: 10 |
Panpharma Laboratories, Франция |
Panpharma Laboratories, Франция |
132.02 |
26.4 |
158.42 |
4% |
5.28 |
137.3 |
27.46 |
164.76 |
16% |
21.12 |
158.42 |
31.68 |
190.1 |
промяна на обстоятелства НСР-1379/07.10.2013; Промяна на обстоятелства НСР-12893/02.06.2017; НСР-12999/15.06.2017 |
КЦ-2120/08.04.2011 |
25.04.2011 |
02.07.2017 |
Активен |
1014 |
| Ceftazidime |
№ ІІ-9546/03.05.2010 |
CEFTAZIDIME PANPHARMA, Powder for solution for injection, 1000, mg, Pack: 10 |
Panpharma Laboratories, Франция |
Helm AG, Германия |
132.02 |
26.4 |
158.42 |
4% |
5.28 |
137.3 |
27.46 |
164.76 |
16% |
21.12 |
158.42 |
31.68 |
190.1 |
промяна на обстоятелства НСР-1379/07.10.2013 |
КЦ-2120/08.04.2011 |
25.04.2011 |
25.04.2011 |
Неактивен |
1014 |
| Ceftazidime |
20150171 |
Ceftazidim-MIP, Powder for solution for injection/infusion, 2000, mg, Pack: 10 |
MIP Pharma GmbH, Германия |
MIP Pharma GmbH, Kirkeler Straße 41 D-66440 Blieskastel, Германия |
191.12 |
38.22 |
229.34 |
4% |
7.64 |
198.76 |
39.75 |
238.51 |
16% |
25 |
223.76 |
44.75 |
268.51 |
|
НСР-8041/08.02.2016.; НСР-12556/05.05.2017 |
20.05.2017 |
02.06.2017 |
Активен |
4182 |
| Ceftazidime |
20150171 |
Ceftazidim-MIP, Powder for solution for injection/infusion, 2000, mg, Pack: 10 |
MIP Pharma GmbH, Германия |
MIP Pharma GmbH, Kirkeler Straße 41 D-66440 Blieskastel, Германия |
191.51 |
38.3 |
229.81 |
4% |
7.66 |
199.17 |
39.83 |
239 |
16% |
25 |
224.17 |
44.83 |
269 |
|
НСР-8041/08.02.2016. |
24.02.2016 |
24.02.2016 |
Неактивен |
4182 |
| Ceftazidime |
20150171 |
Ceftazidim-MIP, Powder for solution for injection/infusion, 2000, mg, Pack: 10 |
MIP Pharma GmbH, Германия |
MIP Pharma GmbH, Kirkeler Straße 41 D-66440 Blieskastel, Германия |
191.51 |
38.3 |
229.81 |
4% |
7.66 |
199.17 |
39.83 |
239 |
16% |
25 |
224.17 |
44.83 |
269 |
|
НСР-8041/08.02.2016. |
24.02.2016 |
24.02.2016 |
Неактивен |
4182 |
| Ceftazidime |
20070109 |
CEFTAZIM, Powder for solution for injection, 1000, mg, Pack: 5 |
Актавис EАД, България |
Балканфарма Разград АД, България |
58.54 |
11.71 |
70.25 |
4% |
2.34 |
60.88 |
12.18 |
73.06 |
16% |
9.37 |
70.25 |
14.05 |
84.3 |
промяна на обстоятелства НСР-11443/13.01.2017 г. |
НСР-5968/01.04.2015.; НСР-15721/25.05.2018 |
09.06.2018 |
02.07.2018 |
Неактивен |
3728 |
| Ceftazidime |
20070109 |
CEFTAZIM, Powder for solution for injection, 1000, mg, Pack: 5 |
Актавис EАД, България |
Балканфарма Разград АД, България |
59.85 |
11.97 |
71.82 |
4% |
2.39 |
62.24 |
12.45 |
74.69 |
16% |
9.58 |
71.82 |
14.36 |
86.18 |
промяна на обстоятелства НСР-11443/13.01.2017 г. |
НСР-5968/01.04.2015. |
16.04.2015 |
02.02.2017 |
Неактивен |
3728 |
| Ceftazidime |
II-1023/16.11.2007 |
CEFTAZIM, Powder for solution for injection, 1000, mg, Pack: 5 |
Актавис EАД, България |
Балканфарма Разград АД, България |
59.85 |
11.97 |
71.82 |
4% |
2.39 |
62.24 |
12.45 |
74.69 |
16% |
9.58 |
71.82 |
14.36 |
86.18 |
|
НСР-5968/01.04.2015. |
16.04.2015 |
16.04.2015 |
Неактивен |
3728 |
| Ceftazidime |
II-1023/16.11.2007 |
CEFTAZIM, Powder for solution for injection, 1000, mg, Pack: 5 |
Актавис EАД, България |
Балканфарма Разград АД, България |
66.5 |
13.3 |
79.8 |
4% |
2.66 |
69.16 |
13.83 |
82.99 |
16% |
10.64 |
79.8 |
15.96 |
95.76 |
|
КЦ-507/06.02.2009 |
19.02.2009 |
19.02.2009 |
Неактивен |
3728 |
| Ceftriaxone |
20050023 |
Ceftriaxone Panpharma, Powder for solution for injection, 1, g, Pack: 10 |
Panpharma Laboratories, Франция |
PANPHARMA Laboratories, France; Biopharma S.r.l., Италия |
70.41 |
14.08 |
84.49 |
4% |
2.82 |
73.23 |
14.65 |
87.88 |
16% |
11.27 |
84.5 |
16.9 |
101.4 |
промяна на обстоятелства НСР-5198/04.12.2014;Протокол № 278/10.05.2018 |
КЦРР-1259/15.08.2012; НСР-17492/13.12.2018 |
14.09.2012 |
02.01.2019 |
Заличен |
1331 |
| Ceftriaxone |
20050023 |
Ceftriaxone Panpharma, Powder for solution for injection, 1, g, Pack: 10 |
Panpharma Laboratories, Франция |
PANPHARMA Laboratories, France; Biopharma S.r.l., Италия |
70.41 |
14.08 |
84.49 |
4% |
2.82 |
73.23 |
14.65 |
87.88 |
16% |
11.27 |
84.5 |
16.9 |
101.4 |
промяна на обстоятелства НСР-5198/04.12.2014;Протокол № 278/10.05.2018 |
КЦРР-1259/15.08.2012 |
14.09.2012 |
02.06.2018 |
Неактивен |
1331 |
| Ceftriaxone |
20050023 |
Ceftriaxone Panpharma, Solution for injection, 1, g, Pack: 10 |
Panpharma Laboratories, Франция |
PANPHARMA Laboratories, France; Biopharma S.r.l., Италия |
70.41 |
14.08 |
84.49 |
4% |
2.82 |
73.23 |
14.65 |
87.88 |
16% |
11.27 |
84.5 |
16.9 |
101.4 |
промяна на обстоятелства НСР-5198/04.12.2014 |
КЦРР-1259/15.08.2012 |
14.09.2012 |
14.09.2012 |
Неактивен |
1331 |
| Ceftriaxone |
20100822 |
Ceftriaxone Panpharma, Powder for solution for injection, 2, g, Pack: 10 |
Panpharma Laboratories, Франция |
PANPHARMA Laboratories, France |
180 |
36 |
216 |
4% |
7.2 |
187.2 |
37.44 |
224.64 |
16% |
25 |
212.2 |
42.44 |
254.64 |
Протокол № 210/09.02.2017;Промяна на обстоятелства НСР-12892/02.06.2017 |
КЦРР-484/19.04.2012 |
06.05.2012 |
02.07.2017 |
Активен |
1188 |
| Ceftriaxone |
20100822 |
Ceftriaxone Panpharma, Solution for injection, 2, g, Pack: 10 |
Panpharma Laboratories, Франция |
PANPHARMA Laboratories, France |
180 |
36 |
216 |
4% |
7.2 |
187.2 |
37.44 |
224.64 |
16% |
25 |
212.2 |
42.44 |
254.64 |
Протокол № 210/09.02.2017 |
КЦРР-484/19.04.2012 |
06.05.2012 |
02.03.2017 |
Неактивен |
1188 |
| Ceftriaxone |
20100822 |
Ceftriaxone Panpharma, Solution for injection, 2, g, Pack: 10 |
Panpharma Laboratories, Франция |
Панфарма Лаборатории Франция |
180 |
36 |
216 |
4% |
7.2 |
187.2 |
37.44 |
224.64 |
16% |
25 |
212.2 |
42.44 |
254.64 |
|
КЦРР-484/19.04.2012 |
06.05.2012 |
06.05.2012 |
Неактивен |
1188 |
| Ceftriaxone |
9368/10.06.2004 г. |
CEFTRIAXONE-TCHAIKAPHARMA, Powder for solution for injection, 1, g, Pack: 10 |
Чайкафарма Висококачествените лекарства АД, България |
Чайкафарма - Висококачествените лекарства АД - гр. Варна |
60 |
12 |
72 |
4% |
2.4 |
62.4 |
12.48 |
74.88 |
16% |
9.6 |
72 |
14.4 |
86.4 |
|
КЦ-165/04.08.2008 |
28.08.2008 |
28.08.2008 |
Неактивен |
78 |
| Ceftriaxone |
№ ІІ-15348/27.12.2006 |
CEFTRIAXON-MIP, Powder for solution for injection, 1, g, Pack: 10 |
MIP Pharma GmbH, Германия |
Chephasaar Chem.-pharm. Fabrik GmbH, Germany |
15.61 |
3.12 |
18.73 |
6% |
0.94 |
16.55 |
3.31 |
19.86 |
18% |
2.81 |
19.36 |
3.87 |
23.23 |
Протокол № 212/23.02.2017 |
КЦ-2047/08.03.2011; НСР-12876/02.06.2017 |
17.06.2017 |
02.07.2017 |
Активен |
1026 |